RUZURGI® (amifampridine)
10 mg Tablets
NOW AVAILABLE TO PRESCRIBE AND COVERED
Medunik Canada is pleased to announce that Ruzurgi® (amifampridine 10 mg tablets) is now available to prescribe and is covered by:
| Provinces | Special Authorization Forms | Coverage Criteria |
|---|---|---|
| Alberta | Download | Alberta Health - Drug Benefit List (bluecross.ca) |
| British-Columbia | Download | SPECIAL AUTHORITY REQUEST AMIFAMPRIDINE |
| Manitoba | Download | List of criteria |
| New Brunswick | Download | Drug Plans Formulary Update |
| Newfoundland Labrador | Download | Bulletin |
| Nova Scotia | Download | List of criteria |
| Ontario | List of resources | |
| Quebec | Download (only available in French) | The criteria are in Annex IV-14 of the list of drugs View list of drugs |
| Saskatchewan | List of criteria |
To reach our medical information service, click here
The information provided on this website is intended for use by residents of Canada for general informational and educational purposes. Certain sections of this website are intended for particular audiences, including Medunik Canada’s employees and customers, as well as members of the healthcare community and the general public.